论文部分内容阅读
目的:观察痰热清注射液治疗儿童急性呼吸道感染的临床疗效。方法:回顾分析2015年11月至2016年11月期间在我院治疗的96例儿童急性呼吸道感染患儿临床资料,将其随机分为对照组和治疗组,每组48例患儿,对照组采用止咳、祛痰、解痉等对症治疗,治疗组在对照组治疗基础上给予痰热清注射液治疗,治疗1个疗程(1个疗程7d),第8天评价两组患儿临床治疗效果。结果:治疗7天后,治疗组患儿临床治疗总有效率95.83%,对照组患儿临床治疗总有效率为77.08%,两组对比差异有统计学意义;治疗后治疗组患儿临床症状(发热、咳嗽、咳痰、气喘)改善时间明显短于对照组;治疗后两组患儿临床症状评分明显降低,与治疗前对比差异有统计学意义,治疗组临床症状评分明显低于对照组;治疗后两组患儿T淋巴细胞、CD4+水平明显升高,治疗组T淋巴细胞、CD4+水平明显高于对照组;治疗后两组患儿白细胞(WBC)、C-反应蛋白(CRP)明显下降,治疗组WBC、CRP明显低于对照组;在治疗和观察期间,对照组出现2例胃肠不良反应,治疗组无不良良反应。结论:痰热清注射液治疗儿童急性呼吸道感染效果显著,可快速改善患儿临床症状,提高患儿免疫功能。
Objective: To observe the clinical effect of Tanreqing Injection in treating acute respiratory infection in children. Methods: The clinical data of 96 children with acute respiratory infection treated in our hospital from November 2015 to November 2016 were retrospectively analyzed. They were randomly divided into control group and treatment group, 48 cases in each group, control group The treatment group was treated with Tanreqing Injection on the basis of the control group, one course of treatment (1 course of treatment for 7 days) and the second day of evaluation of the clinical effect of two groups of children . Results: After 7 days of treatment, the total effective rate of clinical treatment was 95.83% in the treatment group and 77.08% in the control group. The difference between the two groups was statistically significant. After treatment, the clinical symptoms (fever , Cough, sputum, asthma) was significantly shorter than the control group; after treatment, the score of clinical symptom in both groups was significantly lower than that before treatment, the score of clinical symptom in the treatment group was significantly lower than that of the control group; treatment T lymphocytes and CD4 + levels in the latter two groups were significantly increased, T lymphocytes and CD4 + levels in the treatment group were significantly higher than those in the control group; WBC and C-reactive protein (CRP) The treatment group WBC, CRP was significantly lower than the control group; during the treatment and observation period, two cases of gastrointestinal adverse reactions in the control group, the treatment group without any adverse reactions. Conclusion: Tanreqing Injection is effective in treating acute respiratory infection in children and can rapidly improve the clinical symptoms and improve the immune function in children.